Pricing Log in Create free account

SCYNEXIS, Inc. (SCYX) vs Talphera, Inc. (TLPH)

SCYNEXIS, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $55.5M against $38.9M — 1.4× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −73.1%. Talphera, Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (0.00% vs −110.7%). Across the 16 metrics below, SCYNEXIS, Inc. leads on 9 and Talphera, Inc. on 7.

Valuation

Metric SCYX TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.11 191.48 2.11
P/B 0.65 5.66 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.73 166.32 2.73
Earnings yield (56.95%) (25.00%) (4.38%)
Free cash flow yield (30.71%) (11.83%) 0.00%

Profitability

Metric SCYX TLPH Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 100.00% 53.94%
Operating margin (109.90%) 0.00% 0.00%
Net margin (49.74%) 0.00% 0.00%
Free cash flow margin (64.67%) 0.00% 0.00%
Return on equity (18.38%) (143.36%) (0.40%)
Return on assets (15.09%) (69.60%) (3.32%)
Return on invested capital (110.72%) 0.00% 0.00%

Growth

Metric SCYX TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 682.47% (73.07%) 10.01%
EPS growth (last fiscal year) 61.36% 32.00% 49.06%
Revenue growth, 5-year CAGR 179.40% (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SCYX TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 9.65 4.29 2.31
Net debt to EBITDA 2.54 1.50 0.97

Dividend

Metric SCYX TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric SCYX TLPH Drug Manufacturers Specialty & Generic median
Market cap 38.90m 55.54m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack